Vaccine Blurbs Special Edition Issue 188: Correction to PCV 20 in Children Article

1

Washington State Department of Health | July 11, 2023

Pneumococcal 20-valent conjugate (PCV20) vaccine in children

We apologize for any confusion our previous article may have caused in the last edition of the Vaccine Blurbs regarding the Advisory Committee on Immunization Practices (ACIP) PCV20 in children vote in June. Even though ACIP voted on these recommendations, the final ACIP Vaccine Recommendations need to be published before providers can start implementing these recommendations. Below is the corrected information.

ACIP approved recommendations for use of PCV20 in children under 18 years. Below is a summary of the vote by ACIP:

  • Use either PCV15 or PCV20 for all children age 2 through 23 months according to currently recommended PCV dosing and schedules
  • For older children with an incomplete PCV vaccination, use either PCV15 or PCV20 
  • For children 2 through 18 years with any risk condition who have received all recommended doses before age 6 years: 
    • If they received at least 1 dose of PCV20: No additional pneumococcal doses needed
    • If they received PCV13 or PCV15 (but no PCV20): give one dose of PCV20, or PPSV23
  • For children 6 through 18 years with any risk condition who have not received any pneumococcal vaccine, give a single PCV20, or PCV15 followed by a dose of PPSV23 at least 8 weeks later, if not previously given.